Stage IIIB Cutaneous Melanoma AJCC v7 Active Not Recruiting Phase 1 / 2 Trials for Ipilimumab (DB06186)

IndicationStatusPhase
DBCOND0091048 (Stage IIIB Cutaneous Melanoma AJCC v7)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02304458Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or SarcomasTreatment